Cancer Research Translational Cancer Medicine 2008: Cancer Clinical Trials and Personalized Medicine  AACR Conference on Molecular Diagnostics - 2008
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

[Cancer Research 38, 1694-1698, June 1, 1978]
© 1978 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hecht, S. S.
Right arrow Articles by Hoffmann, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hecht, S. S.
Right arrow Articles by Hoffmann, D.

Tumor-initiating Activity of Fluorinated 5-Methylchrysenes1

Stephen S. Hecht2, Norio Hirota, Myrna Loy and Dietrich Hoffmann

Naylor Dana Institute for Disease Prevention, American Health Foundation, Valhalla, New York 10595

The environmental carcinogen, 5-methylchrysene, is more carcinogenic than are any of the other monomethylchrysene isomers or chrysene. For investigation of the site of metabolic activation of 5-methylchrysene, a series of fluorinated 5-methylchrysene derivatives was prepared and tested for tumor-initiating activity on mouse skin. The compounds tested were 1-fluoro-5-methylchrysene, 3-fluoro-5-methylchrysene, 6-fluoro-5-methylchrysene, 7-fluoro-5-methylchrysene, 9-fluoro-5-methylchrysene, 11-fluoro-5-methylchrysene, and 12-fluoro-5-methylchrysene, as well as 5,12-dimethylchrysene and 12-methoxy-5-methylchrysene. Each compound was assayed at total initiating doses of 30 or 100 µg with promotion by three-times weekly application of 2.5 µg of tetradecanoylphorbol acetate. Of the fluoro compounds, 12-fluoro-5-methylchrysene, 1-fluoro-5-methylchrysene, and 3-fluoro-5-methylchrysene were less active than was 5-methylchrysene, whereas 6-fluoro-5-methylchrysene, 7-fluoro-5-methylchrysene, 9-fluoro-5-methylchrysene, and 11-fluoro-5-methylchrysene were as potent as was 5-methylchrysene. Both 5,12-dimethylchrysene and 12-methoxy-5-methylchrysene were also less active than was 5-methylchrysene. These results indicate that positions 12, 1, and 3 of 5-methylchrysene are involved in metabolic activation to the ultimate carcinogen. The requirements favoring carcinogenicity in this series are a bay-region methyl group and an unhindered peri position adjacent to an unsubstituted angular ring.

1 Supported by Grant CA-16352 from the National Cancer Institute. Presented in part at the 68th Annual Meeting of the American Association for Cancer Research, Denver, Colo., May 1977 (11). This is paper 8 of the series, "A Study of Chemical Carcinogenesis." The numbering system for the chrysene ring system is shown in Chart 5.

2 Recipient of Research Career Development Award KO4-CA00124 from the National Cancer Institute.

Received 12/ 5/77. Accepted 2/20/78.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 1978 by the American Association for Cancer Research.